File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients

TitleIncidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients
Authors
Issue Date2020
PublisherNature Publishing Group: Open Access Journals - Option A. The Journal's web site is located at http://www.nature.com/ctg/index.html
Citation
Clinical and Translational Gastroenterology, 2020, v. 11, p. article no. e00196 How to Cite?
AbstractINTRODUCTION: Spontaneous hepatitis B surface antigen (HBsAg) seroclearance, the functional cure of hepatitis B infection, occurs rarely. Prior original studies are limited by insufficient sample size and/or follow-up, and recent meta-analyses are limited by inclusion of only study-level data and lack of adjustment for confounders to investigate HBsAg seroclearance rates in most relevant subgroups. Using a cohort with detailed individual patient data, we estimated spontaneous HBsAg seroclearance rates through patient and virologic characteristics. METHODS: We analyzed 11,264 untreated patients with chronic hepatitis B with serial HBsAg data from 4 North American and 8 Asian Pacific centers, with 1,393 patients with HBsAg seroclearance (≥2 undetectable HBsAg ≥6 months apart) during 106,192 person-years. The annual seroclearance rate with detailed categorization by infection phase, further stratified by hepatitis B e antigen (HBeAg) status, sex, age, and quantitative HBsAg (qHBsAg), was performed. RESULTS: The annual seroclearance rate was 1.31% (95% confidence interval: 1.25–1.38) and over 7% in immune inactive patients aged ≥55 years and with qHBsAg <100 IU/mL. The 5-, 10-, 15-, and 20-year cumulative rates were 4.74%, 10.72%, 18.80%, and 24.79%, respectively. On multivariable analysis, male (adjusted hazard ratio [aHR] = 1.66), older age (41–55 years: aHR = 1.16; >55 years: aHR = 1.21), negative HBeAg (aHR = 6.34), and genotype C (aHR = 1.82) predicted higher seroclearance rates, as did lower hepatitis B virus DNA and lower qHBsAg (P < 0.05 for all), and inactive carrier state. DISCUSSION: The spontaneous annual HBsAg seroclearance rate was 1.31%, but varied from close to zero to about 5% among most chronic hepatitis B subgroups, with older, male, HBeAg-negative, and genotype C patients with lower alanine aminotransferase and hepatitis B virus DNA, and qHBsAg independently associated with higher rates (see Visual Abstract, Supplementary Digital Content 2, http://links.lww.com/CTG/A367).
Persistent Identifierhttp://hdl.handle.net/10722/304488
ISSN
2023 Impact Factor: 3.0
2023 SCImago Journal Rankings: 1.413
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorYeo, YH-
dc.contributor.authorTseng, TC-
dc.contributor.authorHosaka, T-
dc.contributor.authorCunningham, C-
dc.contributor.authorFung, JYY-
dc.contributor.authorHo, HJ-
dc.contributor.authorKwak, MS-
dc.contributor.authorTrinh, HN-
dc.contributor.authorUngtrakul, T-
dc.contributor.authorYu, ML-
dc.contributor.authorKobayashi, M-
dc.contributor.authorLe, AK-
dc.contributor.authorHenry, L-
dc.contributor.authorLi, J-
dc.contributor.authorZhang, J-
dc.contributor.authorSriprayoon, T-
dc.contributor.authorJeong, D-
dc.contributor.authorTanwandee, T-
dc.contributor.authorGane, E-
dc.contributor.authorCheung, RC-
dc.contributor.authorWu, CY-
dc.contributor.authorLok, AS-
dc.contributor.authorLee, HS-
dc.contributor.authorSuzuki, F-
dc.contributor.authorYuen, MF-
dc.contributor.authorKao, JH-
dc.contributor.authorYang, HI-
dc.contributor.authorNguyen, MH-
dc.date.accessioned2021-09-23T09:00:44Z-
dc.date.available2021-09-23T09:00:44Z-
dc.date.issued2020-
dc.identifier.citationClinical and Translational Gastroenterology, 2020, v. 11, p. article no. e00196-
dc.identifier.issn2155-384X-
dc.identifier.urihttp://hdl.handle.net/10722/304488-
dc.description.abstractINTRODUCTION: Spontaneous hepatitis B surface antigen (HBsAg) seroclearance, the functional cure of hepatitis B infection, occurs rarely. Prior original studies are limited by insufficient sample size and/or follow-up, and recent meta-analyses are limited by inclusion of only study-level data and lack of adjustment for confounders to investigate HBsAg seroclearance rates in most relevant subgroups. Using a cohort with detailed individual patient data, we estimated spontaneous HBsAg seroclearance rates through patient and virologic characteristics. METHODS: We analyzed 11,264 untreated patients with chronic hepatitis B with serial HBsAg data from 4 North American and 8 Asian Pacific centers, with 1,393 patients with HBsAg seroclearance (≥2 undetectable HBsAg ≥6 months apart) during 106,192 person-years. The annual seroclearance rate with detailed categorization by infection phase, further stratified by hepatitis B e antigen (HBeAg) status, sex, age, and quantitative HBsAg (qHBsAg), was performed. RESULTS: The annual seroclearance rate was 1.31% (95% confidence interval: 1.25–1.38) and over 7% in immune inactive patients aged ≥55 years and with qHBsAg <100 IU/mL. The 5-, 10-, 15-, and 20-year cumulative rates were 4.74%, 10.72%, 18.80%, and 24.79%, respectively. On multivariable analysis, male (adjusted hazard ratio [aHR] = 1.66), older age (41–55 years: aHR = 1.16; >55 years: aHR = 1.21), negative HBeAg (aHR = 6.34), and genotype C (aHR = 1.82) predicted higher seroclearance rates, as did lower hepatitis B virus DNA and lower qHBsAg (P < 0.05 for all), and inactive carrier state. DISCUSSION: The spontaneous annual HBsAg seroclearance rate was 1.31%, but varied from close to zero to about 5% among most chronic hepatitis B subgroups, with older, male, HBeAg-negative, and genotype C patients with lower alanine aminotransferase and hepatitis B virus DNA, and qHBsAg independently associated with higher rates (see Visual Abstract, Supplementary Digital Content 2, http://links.lww.com/CTG/A367).-
dc.languageeng-
dc.publisherNature Publishing Group: Open Access Journals - Option A. The Journal's web site is located at http://www.nature.com/ctg/index.html-
dc.relation.ispartofClinical and Translational Gastroenterology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleIncidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients-
dc.typeArticle-
dc.identifier.emailFung, JYY: jfung@hkucc.hku.hk-
dc.identifier.emailYuen, MF: mfyuen@hku.hk-
dc.identifier.authorityFung, JYY=rp00518-
dc.identifier.authorityYuen, MF=rp00479-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.14309/ctg.0000000000000196-
dc.identifier.scopuseid_2-s2.0-85094684370-
dc.identifier.hkuros325492-
dc.identifier.volume11-
dc.identifier.spagearticle no. e00196-
dc.identifier.epagearticle no. e00196-
dc.identifier.isiWOS:000575994700002-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats